N-((2-hydroxy-1-hydroxyMethyl)ethyl)-9-oxo-11.alpha.,15S-dihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-aMide
|
- $495.09 - $3080
- Product name: N-((2-hydroxy-1-hydroxyMethyl)ethyl)-9-oxo-11.alpha.,15S-dihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-aMide
- CAS: 1193782-16-9
- MF: C26H37NO6
- MW: 459.58
- EINECS:
- MDL Number:MFCD08062132
- Synonyms:(Z)-N-(1,3-Dihydroxypropan-2-yl)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-;Desisopropyl N-Dihydroxypropyl Dehydrolatanoprostamide;N-((2-hydroxy-1-hydroxyMethyl)ethyl)-9-oxo-11.alpha.,15S-dihydroxy-17-phenyl-18,19,20-trinor-prosta-5Z,13E-dien-1-aMide;(Z)-N-(1,3-Dihydroxypropan-2-yl)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-y;(5Z)-N-[2-Hydroxy-1-(hydroxymethyl)ethyl]-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-5-oxocyclopentyl]-5-heptenamide;5-Heptenamide, N-[2-hydroxy-1-(hydroxymethyl)ethyl]-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]-5-oxocyclopentyl]-, (5Z)-;Molnupiravir Impurity 39;Dihydroxypropyl didehydrolatanoprostamid
5 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Matrix Scientific
- TRC
Package
- 5MG
- 25mg
- 250mg
- 1g
- ManufacturerAK Scientific
- Product number3319AA
- Product description(Z)-N-(1,3-Dihydroxypropan-2-yl)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-5-oxocyclopentyl)hept-5-enamide
- Packaging250mg
- Price$1051
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCCH0033565
- Product description(Z)-N-(1,3-DIHYDROXYPROPAN-2-YL)-7-((1R,2R,3R)-3-HYDROXY-2-((S,E)-3-HYDROXY-5-PHENYLPENT-1-EN-1-YL)-5-OXOCYCLOPENTYL)HEPT-5-ENAMIDE 95.00%
- Packaging5MG
- Price$495.09
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number096226
- Product description(Z)-N-(1,3-Dihydroxypropan-2-yl)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-5-oxocyclopentyl)hept-5-enamide 95+%
- Packaging250mg
- Price$742
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number096226
- Product description(Z)-N-(1,3-Dihydroxypropan-2-yl)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-5-oxocyclopentyl)hept-5-enamide 95+%
- Packaging1g
- Price$1647
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberD297210
- Product descriptionDesisopropylN-DihydroxypropylDehydrolatanoprostamide
- Packaging25mg
- Price$3080
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 3319AA | (Z)-N-(1,3-Dihydroxypropan-2-yl)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-5-oxocyclopentyl)hept-5-enamide | 250mg | $1051 | 2021-12-16 | Buy |
| American Custom Chemicals Corporation | CCH0033565 | (Z)-N-(1,3-DIHYDROXYPROPAN-2-YL)-7-((1R,2R,3R)-3-HYDROXY-2-((S,E)-3-HYDROXY-5-PHENYLPENT-1-EN-1-YL)-5-OXOCYCLOPENTYL)HEPT-5-ENAMIDE 95.00% | 5MG | $495.09 | 2021-12-16 | Buy |
| Matrix Scientific | 096226 | (Z)-N-(1,3-Dihydroxypropan-2-yl)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-5-oxocyclopentyl)hept-5-enamide 95+% | 250mg | $742 | 2021-12-16 | Buy |
| Matrix Scientific | 096226 | (Z)-N-(1,3-Dihydroxypropan-2-yl)-7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)-5-oxocyclopentyl)hept-5-enamide 95+% | 1g | $1647 | 2021-12-16 | Buy |
| TRC | D297210 | DesisopropylN-DihydroxypropylDehydrolatanoprostamide | 25mg | $3080 | 2021-12-16 | Buy |
Properties
Boiling point :737.7±60.0 °C(Predicted)
Density :1.228±0.06 g/cm3(Predicted)
pka :13.78±0.60(Predicted)
Density :1.228±0.06 g/cm3(Predicted)
pka :13.78±0.60(Predicted)
Safety Information
| Symbol(GHS): |
|
|||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | |||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|




